The BH3 activator BIM is highly expressed in cells of hematopoietic origin [163], and evaluation of BH3 activators bound to the anti-apoptotic BCl-2 proteins in MM demonstrated that BIM is the most relevant BH3 activator dictating BCL-2 dependence [164]. This evidence concerns the gene BCL2 and Miyoshi myopathy.